Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Infinity Pharmaceuticals Inc INFIQ

Healthcare Biotechnology
Infinity Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is focused on developing medicines for people with cancer. The Company is focused on advancing eganelisib, also known as IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme phosphoinositide-3-kinase-gamma (PI3K... see more

Recent & Breaking News (GREY:INFIQ)

Infinity Announces Clinical Data to Be Presented at ASCO and ICML

Business Wire May 15, 2013

Infinity to Present at the UBS Global Healthcare Conference

Business Wire May 14, 2013

Infinity Reports First Quarter 2013 Financial Results and Provides Company Update

Business Wire May 7, 2013

Infinity Announces the Date of Its First Quarter 2013 Financial Results Conference Call and Webcast

Business Wire April 24, 2013

Infinity to Present at the Needham 12th Annual Healthcare Conference

Business Wire April 23, 2013

Infinity Announces Closing of Secondary Offering of Common Stock and Exercise of Over-Allotment Option

Business Wire April 16, 2013

Free Research Reports on ACTS, INFI, PSMT and SEAC Issued by the Paragon Report

Marketwired April 11, 2013

Infinity Announces Pricing of Secondary Offering of Common Stock

Business Wire April 11, 2013

Infinity Announces Proposed Secondary Offering of Common Stock

Business Wire April 9, 2013

Infinity to Present at the 25th Annual Roth Conference

Business Wire March 11, 2013

Pipeline Initiatives, Partnerships to Drive Growth - Research Report on Pfizer, Theravance, ISIS Pharmaceuticals, Infinity Pharmaceuticals and Ironwood

PR Newswire March 7, 2013

Infinity Provides Company Update and Reports Full-Year 2012 Financial Results

Business Wire March 5, 2013

Infinity to Present at Upcoming Conferences

Business Wire February 25, 2013

Infinity Announces the Date of Its Full-Year 2012 Financial Results Conference Call and Webcast

Business Wire February 19, 2013

Infinity to Participate in Three Conferences in February

Business Wire February 6, 2013

Infinity Provides Key 2013 Goals and Financial Guidance

Business Wire January 7, 2013

Infinity to Present at the J.P. Morgan Annual Healthcare Conference

Business Wire December 31, 2012

Infinity Amends PI3K-Delta,Gamma Agreement with Millennium

Business Wire December 24, 2012